Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 36.55
-0.05 (-0.14%)
Jan 22, 2026, 10:29 AM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 12.03 billion as of January 21, 2026. Its market cap has increased by 1.39% in one year.
Market Cap
12.03B
Enterprise Value
10.66B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.55
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 12.03B, an increase of 324.42%. That is a compound annual growth rate of 14.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 12.03B | -3.05% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 19.40B |
| TaiMed Biologics | 16.64B |
| AP Biosciences | 14.46B |
| Ever Supreme Bio Technology | 13.75B |
| Tanvex BioPharma | 13.53B |
| TCM Biotech International | 10.92B |
| PharmaEngine | 10.09B |
| TaiGen Biopharmaceuticals Holdings | 10.07B |